Kestra Private Wealth Services’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-100,300
Closed -$1.8M – 991
2021
Q3
$1.8M Buy
+100,300
New +$2M 0.1% 223

Other funds holding AVXL

Kestra Private Wealth Services's AVXL Position: Q4 2021 in Review

Kestra Private Wealth Services sold out of Anavex Life Sciences (AVXL) in Q4 2021, closing a stake of 100,300 shares — an estimated $1.8M sold.

Kestra Private Wealth Services first reported a position in AVXL in Q3 2021 and held it in 1 quarter. The position peaked at $1.8M in Q3 2021. 149 funds tracked by Wall St. Rank hold AVXL as of Q4 2021.

  • Kestra Private Wealth Services reported no remaining Anavex Life Sciences position as of Q4 2021 after selling out during the quarter.
  • Kestra Private Wealth Services sold 100,300 Anavex Life Sciences shares in Q4 2021, an estimated $1.8M.
  • Kestra Private Wealth Services first reported a position in Anavex Life Sciences in Q3 2021 and held it in 1 quarter.
  • Kestra Private Wealth Services's Anavex Life Sciences position peaked at $1.8M in Q3 2021.
  • 149 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2021.

Based on Kestra Private Wealth Services's 13F filing for Q4 2021, filed 21 Jan 2022.